Status:
UNKNOWN
Study Evaluating the Impact of Short Message Service on Compliance With Surveillance of Patients With Germ-cell Tumors
Lead Sponsor:
Centre Hospitalier Universitaire de Besancon
Conditions:
Follow-up
Compliance, Patient
Eligibility:
MALE
18+ years
Brief Summary
This study will evaluate the impact of Short Message Service (SMS) on compliance with surveillance of patients with germ-cell tumors. Patients will be randomized in a 2:1 ratio to get 2 groups : (1) p...
Eligibility Criteria
Inclusion
- Patient with germ cell tumor.
- Patient with a mobile phone.
- Patient on surveillance.
Exclusion
- Testicular cancer without germ cell component.
- Prior history of other malignancy except for: cutaneous cancers excluding melanoma, superficial bladder tumor, localized prostate cancer with undetectable PSA.
- Cognitive condition that would preclude patient's understanding and completion of study procedures.
Key Trial Info
Start Date :
February 28 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2021
Estimated Enrollment :
235 Patients enrolled
Trial Details
Trial ID
NCT03868176
Start Date
February 28 2019
End Date
August 1 2021
Last Update
March 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Besancon
Besançon, Franche-Comté, France, 25030